An Indian-origin family in Canada's Brampton is trying to raise $5.5 million to take their two-year-old son to the United States for a specialized gene therapy that they hope could transform his life after he was diagnosed with a rare genetic disorder.
uncertain
he → try → disorder
Mandeep Chandi and his wife Ramandeep are seeking funds for their son, Zorawar, who suffers from Aromatic L-amino Acid Decarboxylase (AADC) deficiency, a rare genetic condition that affects the nervous system and prevents the brain from producing an enzyme needed to make essential neurotransmitters.
asserted
that → seek → neurotransmitters
The disorder affects the production of dopamine and serotonin, chemical messengers that play a crucial role in controlling movement and other bodily functions.
asserted
that → affect → movement
At two-and-a-half years old, Zorawar has been unable to achieve basic developmental milestones such as sitting, walking and talking.
asserted
Zorawar → achieve → milestones
Ramandeep Kaur, his mother, told CTV News that every day is a challenge for Zorawar.
asserted
day → tell → Zorawar
Several times a week, his eyes will stay rolled upward for up to 30 minutes, which is painful for him.
asserted
which → stay → him
And he can't chew food.
asserted
he → chew → food
“Sometimes he is very irritated, cry all the day, and he is not able to — like he can’t say anything about what is going on with him,” Kaur said.
asserted
Kaur → cry → him
"He's just in a newborn situation right now, his brain isn't able to get the proper function," his father Mandeep told INSAUGA Canada.
asserted
father → get → Canada
"He's not able to walk, talk or sit.
asserted
He → walk → ?
He can't do anything, he just sits in his mom's lap 24/7."
asserted
he → do → lap
Mandeep, who moved to Canada from India in 2015, said caring for their son has been an emotionally and financially challenging experience for the family.
asserted
caring → move → family
Family turns to US for gene therapy
The family is hoping to access a treatment called KEBILIDI, a gene therapy approved by the US Food and Drug Administration (FDA) for patients with AADC deficiency.
asserted
family → turn → deficiency
The treatment, developed for the rare disorder, is administered directly into the brain and is designed to address the underlying genetic problem.
asserted
treatment → develop → problem
According to Boston Children's Hospital, KEBILIDI became the first FDA-approved gene therapy for AADC deficiency.
uncertain
KEBILIDI → accord → deficiency
However, the treatment is not approved in Canada.
asserted
treatment → approve → Canada
Mandeep believes the therapy could give his son a chance at achieving developmental milestones that have so far remained out of reach.
uncertain
that → believe → reach
The family says the procedure itself takes approximately eight hours, with potential improvements becoming noticeable over the following months.
asserted
improvements → say → months
However, treatment requires specialist assessment, and outcomes cannot be guaranteed.
asserted
outcomes → require → assessment
The family had approached Ontario's Ministry of Health seeking funding for treatment outside Canada, but its application was denied.
asserted
application → approach → Canada
With no other viable option currently available to them, the parents have turned to crowdfunding to raise the money needed to pursue treatment in Boston.
asserted
parents → turn → Boston
The family has launched a GoFundMe campaign with a target of $5.5 million Canadian dollars.
asserted
family → launch → dollars
As of November 14, the fundraiser had collected more than $1.5 million, with approximately 29% of its target reached.
asserted
% → collect → target
The family has appealed to the community to support their efforts, saying they want to give their son an opportunity to access treatment that could potentially improve his quality of life.
uncertain
that → appeal → life